Company Filing History:

7 out of 158

Transgene S.a.

Hoechst Marion Roussel

patents

Years Active: 1992-2012

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8173402 - Modified yeasts and uses thereof, in particular for producing steroid derivatives (2012-05-08),

2. 7977065 - Yeast strains autonomously producing steroids (2011-07-12),

3. 7879592 - Modified yeasts and uses thereof, in particular for producing steroid derivatives (2011-02-01),

4. 7670829 - Yeast strains autonomously producing steroids (2010-03-02),

5. 6503749 - Yeast strains possessing the interrupted ATF2 gene and their applications (2003-01-07),

6. 6277822 - Family of peptides known as xenoxins (2001-08-21),

7. 6218139 - Yeast strains possessing the interrupted ATF2 gene and their applications (2001-04-17),

8. 6077827 - Family of peptides known as xenoxins (2000-06-20),

9. 5952195 - Promoters for expressing proteins of interest in yeast (1999-09-14),

10. 5879926 - Yeast strains for the production of mature heterologous proteins, (1999-03-09),

11. 5631144 - Application of novel DNA fragments as a coding sequence for a signal (1997-05-20),

12. 5521093 - Yeast vector coding for heterologous gene fusions linked via KEX2 (1996-05-28),

13. 5162208 - Saccharomyces cerevisiae strain productive of a heterologous protein and (1992-11-10),

Title: Tilman Achstetter: Innovator in Yeast Biotechnology

Introduction

Tilman Achstetter is a prominent inventor based in Oberkirch, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of modified yeast strains for the production of steroid derivatives. With a total of 13 patents to his name, Achstetter's work has paved the way for advancements in therapeutic and prophylactic products.

Latest Patents

Achstetter's latest patents include innovative methods and yeast strains that enhance the synthesis of steroidal compounds. One notable invention is focused on modified yeasts and their applications in producing steroid derivatives. This invention describes novel yeast strains with reduced 20α-HSD type activity, achieved by modifying the GCY1 and/or YPR1 genes. These strains improve the efficiency and selectivity of steroid synthesis, ultimately enhancing the quality of the final products. Another significant patent involves genetically modified yeast strains that autonomously produce steroids from simple carbon sources, along with methods for their production.

Career Highlights

Throughout his career, Tilman Achstetter has worked with notable companies such as Transgene S.A. and Aventis Pharma S.A. His expertise in yeast biotechnology has been instrumental in advancing research and development in the pharmaceutical industry.

Collaborations

Achstetter has collaborated with esteemed colleagues, including Gilles Cauet and Eric Degryse. These partnerships have contributed to the success of his innovative projects and the advancement of yeast biotechnology.

Conclusion

Tilman Achstetter's contributions to yeast biotechnology and his numerous patents highlight his role as a leading inventor in the field. His work continues to influence the development of therapeutic products, showcasing the importance of innovation in biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

5 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com